Amazing conference dinner at Luna park Sydney! ICFTD 2018

Our Research Fellow Nikil Patel will be presenting language impairments in PSP and CBS compared to PNFA on behalf of @kapeterson14. Please come along to poster W98 today to see our latest results. ICFTD 2018 Cambridge FTD #endFTD #ppa Peter Garrard

Please also come to my poster today at number 36 and 37 for more interesting findings about the role of cerebellum in frontotemporal dementia #Icftd2018

Thank you for joining us at ICC Sydney for #ICFTD2018. We wish all the delegates safe travels and all the very best for the rest of the year. Dementia Centre HammondCare

Dr Dennis Dickson presents clinicopathological comparisons of GRN/C9orf72 - suggests greater microglial dysfunction in FTD-GRN. Also, FTD-GRN typically presented with asymmetric clinical features and atrophy while C9 often had symmetry in clinical features and atrophy #icftd2018

The third day of ICFTD 2018 #icftd2018 - (nearly) last but certainly not least the great Charles Marshall highlighting the impaired emotional processing in FTD

Smoothly does it, the brilliant @cjdhardy chairing this afternoons session ICFTD 2018 introducing the great Charles Marshall #icftd2018 #dreamteam #PPA RareDementiaSupport PPA Support UK UCL

Chiadi Onyike Johns Hopkins University: “My hopes: that we can develop biomarkers that will allow us to make an affirmative diagnosis, & for refinements in clinical measurements, esp. for the transition from asymptomatic to symptomatic in mutation carriers… #icftd2018 #hopefor2020

Dr Zac Chatterton discusses early proof of concept evidence supporting development of liquid biopsies for detection of neurodegeration. Brain & Mind Centre Frontier at Brain & Mind Centre #icftd2018 #endftd

Jary Larsen, FTD Disorders Registry: My hope for the next 2 years is that we'll have treatment interventions in the pipeline, especially for the genetic forms of FTD” #icftd2018 #hopefor2020

Dr Marsel Mesulam, our final speaker for #icftd2018, provides a justification for multicentre trials of cholinesterase inhibitors for #PPA patients that have AD biomarkers, based on evidenced cholinergic denervation in areas that match the clinical profile of #PPA. #endftd

Congratulations to Siddharth Ramanan, PhD for winning the best student abstract!

Congratulations to Dr Michael Ward for winning best #ECR abstract

Bruce Miller UC San Francisco: “I’m an optimist. In the next 2 years, I hope and believe that we will have effective disease-modifying therapies for the genetic forms of FTD.” #icftd2018 #hopefor2020 #endFTD

A fantastic end to #icftd2018! Thank you to all the speakers, delegates, organisers and of course the patients and their families without whom this important research wouldn’t be possible. #endFTD Olivier Piguet

Congratulations to both Ione Woollacott and Martina Bocchetta from team FTDtalk who won the runners up prize in the PhD and postdoctoral categories. #icftd2018

What a fantastic meeting! Team @ftdtalk have learned a huge amount, made lots of new collaborations and can’t wait to see where the FTD field has got to by Minneapolis in 2020! #icftd2018

Cheers to ICFTD 2018 organizers for a tremendous meeting and for creating an extraordinary home away from home in Sydney these last 3 days. And thanks to all participants for your continued commitment to #endFTD. See you in Minneapolis October 7-10, 2020 for #icftd2020!

Really delighted to have my work recognised by ICFTD 2018, and also delighted for the notorious RBJ.

alzforum.org/news/conferenc…